Sign In
25 Oct 2013 09:48
For immediate release | 25 October 2013 |
ABCAM PLC
("Abcam" or "the Company")
Director/PDMR dealing: Share Incentive Plan
Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the supply of protein research tools, has today been notified of the following transactions under the Abcam plc Share Incentive Plan to the benefit of the Executive Directors and PDMRs in line with the regular annual invitation to participate:
Name | Partnership Shares purchased on 24 October 2013 at 509.25p per 0.2 pence Ordinary Share | Matching Shares granted on 24 October 2013 at 509.25p per 0.2 pence Ordinary Share | Free Shares awarded on 24 October 2013 at 509.25p per 0.2 pence Ordinary Share | |
Executive Directors: | Jonathan Milner | 295 | 295 | 589 |
Jim Warwick | 295 | 295 | 589 | |
Jeff Iliffe | 295 | 295 | 589 | |
PDMRs: | Mark Bushfield | 24 | 24 | 589 |
Jane Cooke | 294 | 294 | 589 | |
Philippe Cotrel | 24 | 24 | 589 | |
Alan Hirzel | 294 | 294 | 589 | |
Danielle Miller | 294 | 294 | 589 | |
Ed Ralph | 295 | 295 | 589 |
The risk of forfeiture attached to the Matching Shares will normally be removed on the third anniversary of the award subject to continued employment and the retention of the Partnership Shares in connection with which they were awarded. The risk of forfeiture attached to the Free Shares will normally be removed on the third anniversary of the award subject to continued employment.
No consideration was paid by the above grantees for the award of the Matching and Free Shares and no consideration is due on the release of these shares.
For further information please contact:
Abcam | + 44 (0) 1223 696 000 |
Jeff Iliffe, Chief Financial Officer
| |
Numis Securities - Nominated Adviser & Joint Broker | + 44 (0) 20 7260 1000 |
Michael Meade - Nominated Adviser | |
James Black - Corporate Broking
| |
Peel Hunt LLP - Joint Broker | + 44 (0) 20 7418 8900 |
Andy Crossley - Corporate Broking
| |
Buchanan | + 44 (0) 20 7466 5000 |
Mark Court / Fiona Henson / Sophie Cowles |
Notes for editors:
About Abcam plc
Abcam plc is a leading provider of protein research tools and services, with a wide range of products and expert technical support, enabling scientists to analyse living cells at the molecular level to improve the understanding of health and disease.
Abcam is committed to providing scientists with access to the correct reagents and tools for their research. The Company's catalogue currently comprises more than 124,500 products and is continually evolving to meet customer needs. The range offered includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. Abcam products are supported with detailed, up-to-date and unbiased data on our website.
Headquartered in Cambridge, UK, Abcam has eight global subsidiary offices and ships to over 100 countries. The Company was founded in 1998, and now employs over 700 people. Abcam is quoted on the AIM market of the London Stock Exchange (AIM: ABC).
To find out more, please visit www.abcam.com
Follow the stocks
